GetTopicDetailResponse(id=1a159962b9, topicName=INVOKANA, introduction=INVOKANA, content=null, image=null, comments=4, allHits=1703, url=https://h5.medsci.cn/topic?id=9962, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=19457, tagList=[TagDto(tagId=19457, tagName=INVOKANA)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1256954, encodeId=e6661256954b9, content=<a href='/topic/show?id=1a159962b9' target=_blank style='color:#2F92EE;'>#INVOKANA#</a>, objectTitle=III期臨床試驗(yàn)證實(shí)，強(qiáng)生的SGLT2抑制劑Invokana可降低糖尿病患者患糖尿病腎病的風(fēng)險(xiǎn), objectType=article, longId=164340, objectId=bc7c1643405d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc7c1643405d, replyNumber=0, likeNumber=94, createdTime=2019-04-17, rootId=0, userName=仁醫(yī)06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc7c1643405d, moduleTitle=III期臨床試驗(yàn)證實(shí)，強(qiáng)生的SGLT2抑制劑Invokana可降低糖尿病患者患糖尿病腎病的風(fēng)險(xiǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bc7c1643405d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256953, encodeId=a7b612569532e, content=<a href='/topic/show?id=1a159962b9' target=_blank style='color:#2F92EE;'>#INVOKANA#</a>, objectTitle=強(qiáng)生降糖藥INVOKANA顯著改善老年群體血糖及健康措施, objectType=article, longId=36960, objectId=8f6236960df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f6236960df, replyNumber=0, likeNumber=91, createdTime=2014-06-26, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f6236960df, moduleTitle=強(qiáng)生降糖藥INVOKANA顯著改善老年群體血糖及健康措施, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8f6236960df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256952, encodeId=842d125695260, content=<a href='/topic/show?id=1a159962b9' target=_blank style='color:#2F92EE;'>#INVOKANA#</a>, objectTitle=強(qiáng)生糖尿病新藥INVOKANA獲歐盟批準(zhǔn), objectType=article, longId=27074, objectId=00f42e07433, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00f42e07433, replyNumber=0, likeNumber=79, createdTime=2013-11-27, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00f42e07433, moduleTitle=強(qiáng)生糖尿病新藥INVOKANA獲歐盟批準(zhǔn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=00f42e07433)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256951, encodeId=4657125695165, content=<a href='/topic/show?id=1a159962b9' target=_blank style='color:#2F92EE;'>#INVOKANA#</a>, objectTitle=MD Consult：Invokana獲準(zhǔn)用于2型糖尿病, objectType=article, longId=17146, objectId=74171e146e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74171e146e8, replyNumber=0, likeNumber=0, createdTime=2013-04-12, rootId=0, userName=d830372, userId=80a244, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74171e146e8, moduleTitle=MD Consult：Invokana獲準(zhǔn)用于2型糖尿病, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=74171e146e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
